← Eichor
Condition: Clear Cell Renal Carcinoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Clear Cell Renal Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Contrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized C
Phase N/A · 1 location(s) · Mingzhao Xiao · NCT06088134Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06940518Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05155033Imaging of Solid Tumors Using 18F-TRX
Phase 1 · 1 location(s) · Rahul Aggarwal · NCT0694210468Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma
NA · 1 location(s) · Peking University First Hospital · NCT06519760Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell
Phase 1/Phase 2 · 1 location(s) · University of Michigan Rogel Cancer Center · NCT06866262A Study of MGC026 in Participants With Advanced Solid Tumors
Phase 1 · 12 location(s) · MacroGenics · NCT06242470A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works
Phase 1/Phase 2 · 11 location(s) · Regeneron Pharmaceuticals · NCT06413680The Safety and Efficacy of Allogeneic CD70 CAR-T Therapy in Unresectable or Metastatic Clear Cell Renal Cell Carcinoma
EARLY_Phase 1 · 3 location(s) · Chinese PLA General Hospital · NCT07645690A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
Phase 2 · 2 location(s) · Stephanie Berg · NCT07123090Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT00001238A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced
Phase 2 · 6 location(s) · M.D. Anderson Cancer Center · NCT06708949Phase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Treatment Refr
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT07072234Iparomlimab and Tuvonralimab (QL1706) Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT07389629A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
Phase 1/Phase 2 · 4 location(s) · Cancer Research UK · NCT06380816A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
Phase 1 · 25 location(s) · Arcus Biosciences, Inc. · NCT05536141Pucotenlimab Combination With Vorolanib as Neoadjuvant Therapy for ccRCC
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT07386158Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
Phase 2 · 6 location(s) · Vanderbilt-Ingram Cancer Center · NCT05361720Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell Carcinoma
Phase 2 · 1 location(s) · Jinling Hospital, China · NCT07571551An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cel
Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT06447103Radiopharmaceutical Treatment of Advanced Kidney Cancer
Phase 2 · 2 location(s) · European Organisation for Research and Treatment of Cancer - · NCT06783348Dual-energy SPEctral CT to Evaluate Response to First-line Therapies in Patients With Metastatic Clear Cell REnal Cancer
Phase N/A · 2 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06863857Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Phase 1 · 30 location(s) · Calico Life Sciences LLC · NCT04777994Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma
Phase N/A · 1 location(s) · The Affiliated Hospital of Qingdao University · NCT06916624Rapid Sequencing of Approved Therapies in Patients with Metastatic or Unresectable Clear Cell Renal Cell Carcinoma
EARLY_Phase 1 · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT05188118Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Adva
Phase 1/Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT05663710The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN Trial
NA · 3 location(s) · Yonsei University · NCT05753839A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With C
Phase 1 · 41 location(s) · Genentech, Inc. · NCT05581004A Study of HS-10516 in Patients With VHL Syndrome Associated Tumors
Phase 1 · 1 location(s) · Jiangsu Hansoh Pharmaceutical Co., Ltd. · NCT06553339Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT07023432
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.